Microbiological Background

BC30
Genus: Bacillus
Species: B. coagulans
Strain: Bacillus coagulans GBI-30, 6086

Bacillus coagulans was first isolated and described in 1933 and was elaborated in the fifth edition of Bergey's Manual of Determinative Bacteriology. It was initially considered to be a spore-forming Lactobacillus. Since Bacillus coagulans exhibits characteristics typical of both genera Lactobacillus and Bacillus, its taxonomic position between the families Lactobacillaceae and Bacillaceae was often debated. However, in the seventh edition of Bergey's, Bacillus coagulans was finally transferred to the genus Bacillus. DNA-based technology was used in distinguishing between the two species of bacteria which are morphologically similar and possess similar physiological and biochemical characteristics.

  • Bacillus coagulans is a Gram-positive spore-forming rod 0.9u by 3.0u to 5.0u in size, aerobic to microaerophilic.

  • On activation of spore formation in the acidic environment of the stomach, this organism can germinate and proliferate in the intestine, producing the favored L (+) optical isomer of lactic acid.

  • Bacillus coagulans provides a biotherapeutic platform for several potentially useful applications.
Sustenex® is the only widely available probiotic supplement with Bacillus coagulans.

Sustenex® chose to include BC30 because of its ability to survive stomach acidity and intestinal bile and for its ability to colonize the intestines.

Learn more about Sustenex® with BC30 >>

Acidophilus

Acidophilus is the general name used to group together bacteria that help in digestion. While many bacteria strains claim to be acidophilus, Lactobacillus acidophilus (L. acidophilus) is the only true acidophilus strain. Many US manufacturers however, still use acidophilus more as a general name for mixtures of bacteria, one of which is Lactobacillus acidophilus. Sustenex® chose not to pursue a Lactobacillus strain. Instead, it chose a strain of Bacillus coagulans, BC30.
Sustenex®. For Every Body, Every Day.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any diseases.
**Based on median % survivability of BC30 probiotic vs. probiotic supplements and 20 probiotic yogurts in simulated gastric pH for 2 hours. Survivability and delivery of probiotic cells to the small & large intestines is one of several factors influencing overall product effect.

Home | About Sustenex® | 14-Day Challenge | What are Probiotics? | Intestinal Health | For Health Professionals |
Share Your Story | FAQs | Where to Buy | Contact Us | Digestive Advantage | Privacy Policy

www.sustenex.com

© Schiff Nutrition Group, Inc.